Kristine Hole

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents.

Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents.

Journal: European journal of clinical pharmacology

Published: May 01, 2025

Association Between CYP2D6 Genotypes and Serum Concentrations of Mirtazapine and Mianserin.

Association Between CYP2D6 Genotypes and Serum Concentrations of Mirtazapine and Mianserin.

Journal: Basic & clinical pharmacology & toxicology

Published: December 09, 2024

Access to a tailored mobile application enhances medication adherence among young users of antidepressants.

Access to a tailored mobile application enhances medication adherence among young users of antidepressants.

Journal: Frontiers in pharmacology

Published: January 31, 2024

Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.

Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.

Journal: European journal of clinical pharmacology

Published: January 17, 2024

Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population.

Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population.

Journal: British journal of clinical pharmacology

Published: January 09, 2024

Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals.

Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals.

Journal: European journal of clinical pharmacology

Published: October 30, 2023

Effect of CYP2D6 genotype on duloxetine serum concentration.

Effect of CYP2D6 genotype on duloxetine serum concentration.

Journal: Basic & clinical pharmacology & toxicology

Published: August 25, 2023

Impact of CYP2D6 Genotype on Paroxetine Serum Concentration.

Impact of CYP2D6 Genotype on Paroxetine Serum Concentration.

Journal: Therapeutic drug monitoring

Published: April 04, 2023

Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients - a study based on a cohort of 19,742 patients.

Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients - a study based on a cohort of 19,742 patients.

Journal: EBioMedicine

Published: March 29, 2023

Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".

Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".

Journal: European journal of clinical pharmacology

Published: August 24, 2022

Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Journal: European journal of clinical pharmacology

Published: April 06, 2022

Identification of Escitalopram Metabolic Ratios as Potential Biomarkers for Predicting CYP2C19 Poor Metabolizers.

Identification of Escitalopram Metabolic Ratios as Potential Biomarkers for Predicting CYP2C19 Poor Metabolizers.

Journal: Therapeutic drug monitoring

Published: February 10, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026